drugset / Trial / NCT00017992

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

NCT00017992

Phase 2 Unknown 100 enrolled Triangle Pharmaceuticals
Treatment

Summary

The purpose of this study is to see if emtricitabine is safe in children infected with HIV and to determine the best dose.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject emtricitabine Other / unclassified
Background Lopinavir/Ritonavir Unknown
Background Stavudine Other / unclassified